Trial Profile
Study of step down from high dose of salmeterol/fluticasone propionate combination(SFC) with tiotropium to middle dose of SFC + ciclesonide(CIC) with tiotropium in well controlled asthmatic patients with COPD
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2015
Price :
$35
*
At a glance
- Drugs Ciclesonide (Primary) ; Salmeterol/fluticasone propionate (Primary) ; Tiotropium bromide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 16 Feb 2011 New trial record